← All diseases
Liver, kidneys and digestion
Chronic kidney disease, stage 4-5
Would you like to receive a message when new research about chronic kidney disease, stage 4-5 becomes available? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above every publication explaining what was studied — and you'll be notified as soon as new research on Chronic kidney disease, stage 4-5 is available. View what Premium costs.
Publications and studies (2813)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease. (2024/03/01) ♡
- Ameliorative effects of Modified Huangqi Chifeng decoction on podocyte injury via autophagy mediated by PI3k/AKT/mTOR and AMPK/mTOR pathways. (2024/03/01) ♡
- Effect and mechanism of aqueous extract of Chinese herbal prescription (TFK) in treating gout arthritis (2024/03/01) ♡
- Estimated rates of progression to tuberculosis disease for persons infected with Mycobacterium tuberculosis in the United States. (2024/03/01) ♡
- SARS-CoV-2 Antibody Seroprevalence and Humoral Response to Vaccination in Patients Undergoing Maintenance Hemodialysis: A Prospective Cohort Study. (2024/03/01) ♡
- Longitudinal Assessment of Health-Related Quality of Life in Three Different Hyperphosphatemia Management Groups of Stage III and IV Chronic Kidney Disease Patients. (2024/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Rugger-Jersey Spine in Chronic Kidney Disease. (2024/03/01) ♡
- Prevalence and Predictive Factors of Rhabdomyolysis in COVID-19 Patients: A Cross-Sectional Study. (2024/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Attenuating Renal Interstitial Fibrosis by Shenqi Pill via Reducing Inflammation Response Regulated by NF-κB Pathway In Vitro and In Vivo. (2024/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Valacyclovir Neurotoxicity in Patients with End-Stage Renal Disease: Two Cases Reviewed. (2024/02/01) ♡
- Vascular endothelial cell-specific overexpression of CNP did not improve liver fibrosis in HFFCD-induced NASH, but did improve renal lesions. (2024/02/01) ♡
- Coffee consumption and risk of kidney function decline in a Dutch population-based cohort. (2024/02/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. SGLT2 inhibitor improves kidney function and morphology by regulating renal metabolism in mice with diabetic kidney disease. (2024/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy of parsley seed-supplemented bread in improving serum osteopontin level and renal health in obese women: A nutritional intervention study. (2024/02/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Can curcumin supplementation break the vicious cycle of inflammation, oxidative stress, and uremia in patients undergoing peritoneal dialysis? (2024/02/01) ♡
- The effect and mechanism of Qingre Huashi formula in the treatment of chronic hepatitis B with Gan-dan-shi-re syndrome: An integrated transcriptomic and targeted metabolomic analysis. (2024/01/30) ♡
- Guben Xiezhuo Decoction inhibits M1 polarization through the RAF1/p-ELK1 signaling axis to attenuate renal interstitial fibrosis. (2024/01/30) ♡
- Exploring the clinical efficacy and mechanism of high-position colon dialysis combined with Traditional Chinese Medicine retention enema in real-world patients with stage 3-5 chronic kidney disease (non-dialysis) based on the theory of the Gut-Kidney axis. (2024/01/24) ♡
- Prevalence of chronic kidney disease and metabolic related indicators in Mianzhu, Sichuan, China. (2024/01/17) ♡
- Association of phthalate exposure with all-cause mortality across renal function status: The U.S. National Health and Nutrition Examination Survey, 2005-2018. (2024/01/15) ♡
- Association between dietary antioxidant levels and chronic obstructive pulmonary disease: a mediation analysis of inflammatory factors. (2024/01/08) ♡
- Role of symbiotic microbiota dysbiosis in the progression of chronic kidney disease accompanied with vascular calcification. (2024/01/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The importance of the gut microbiome and its signals for a healthy nervous system and the multifaceted mechanisms of neuropsychiatric disorders. (2024/01/05) ♡
- Renal and survival benefits of seventeen prescribed Chinese herbal medicines against oxidative-inflammatory stress in systemic lupus erythematosus patients with chronic kidney disease: a real-world longitudinal study. (2024/01/03) ♡
- Safety and feasibility of thoracoscopic pericardial window in recurrent pericardial effusion - A single-centre experience. (2024/01/01) ♡
- Comparison of three equations for estimating glomerular filtration rate as predictors of cisplatin-related acute kidney injury in lung cancer patients with normal renal function. (2024/01/01) ♡
- Pharmacological potential of Astragali Radix for the treatment of kidney diseases. (2024/01/01) ♡
- Gualou xiebai decoction ameliorates cardiorenal syndrome type II by regulation of PI3K/Akt/NF-βB signalling pathway. (2024/01/01) ♡
- In-Center Automated Peritoneal Dialysis: Clinical Features, Practice Patterns, and Patient Survival from a 6-Year Cohort Study in China. (2024/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Natural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems. (2024/01/01) ♡
- Associations between Total Immunoglobulin E Levels and Urinary Albumin Excretion: A Cross-Sectional Study. (2024/01/01) ♡
- Self-reported childhood adversity, unhealthy lifestyle and risk of new-onset chronic kidney disease in later life: A prospective cohort study. (2024/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Diet is a Foundational to the Management of Chronic Kidney Disease. (2024/01/01) ♡
- Validation of glomerular filtration estimation equations adjustable by race/colour in adults from Vitória, Espirito Santo, Brazil. (2024/01/01) ♡
- Noninvasive scores are poorly predictive of histological fibrosis in paediatric fatty liver disease. (2024/01/01) ♡
- Assessment of Dietary Acid Load in Children with Chronic Kidney Disease: An Observational Study. (2024/01/01) ♡
- Nationwide Trends and Outcomes for Coronary Artery Bypass Grafting in End-Stage Kidney Disease and Stable Coronary Artery Disease. (2024/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Update on drug-resistant pulmonary tuberculosis treatment in hemodialysis patients. (2024/01/01) ♡
- Multicenter Study to Validate a Hospitalization Risk Assessment Tool in Hemodialysis Patients. (2023/12/31) ♡
- The Evolving Landscape of Gout in the Female: A Narrative Review. (2023/12/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Narrative Review: Clinical Implications and Assessment of Frailty in Patients With Advanced CKD. (2023/12/30) ♡
- Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US Adults. (2023/12/29) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Jian-Pi-Yi-Shen formula alleviates renal fibrosis by restoring NAD+ biosynthesis in vivo and in vitro. (2023/12/28) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Biological Activities of Molecules Derived from Olea europaea L. Tested In Vitro (2023/12/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Oxalate Nephropathy: A Case Report of Acute Kidney Injury Due to Juice Diet. (2023/12/28) ♡
- Circulating Oxalate Levels in Short Bowel Syndrome as a Severity Marker of CKD. (2023/12/28) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Outcomes of COVID-19 infection in patients on dialysis and kidney transplant recipients: A single-centre audit. (2023/12/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Vegetarian Nutrition in Chronic Kidney Disease. (2023/12/25) ♡
- Fibroblast Growth Factor (FGF) 23 and FGF Receptor 4 promote cardiac metabolic remodeling in chronic kidney disease. (2023/12/23) ♡
- Peripheral Neuropathy Associated with Higher Mortality in Population with Chronic Kidney Disease: National Health and Nutrition Examination Surveys. (2023/12/23) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.